Metropolitan Life Insurance Company (MetLife)’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $4.87M | Sell |
|
|||||
|
2021
Q1 | $4.33M | Sell |
|
|||||
|
2020
Q4 | $4.64M | Sell |
|
|||||
|
2020
Q3 | $3.58M | Sell |
|
|||||
|
2020
Q2 | $3.69M | Sell |
|
|||||
|
2020
Q1 | $3.62M | Sell |
|
|||||
|
2019
Q4 | $4.41M | Sell |
|
|||||
|
2019
Q3 | $4.04M | Sell |
|
|||||
|
2019
Q2 | $5.47M | Buy |
|
|||||
|
2019
Q1 | $5.32M | Sell |
|
|||||
|
2018
Q4 | $3.98M | Sell |
|
|||||
|
2018
Q3 | $5.75M | Sell |
|
|||||
|
2018
Q2 | $5.26M | Buy |
|
|||||
|
2018
Q1 | $4.68M | Sell |
|
|||||
|
2017
Q4 | $5.04M | Sell |
|
|||||
|
2017
Q3 | $15.9M | Sell |
|
|||||
|
2017
Q2 | $14M | Sell |
|
|||||
|
2017
Q1 | $14.4M | Sell |
|
|||||
|
2016
Q4 | $14.8M | Sell |
|
|||||
|
2016
Q3 | $15.2M | Sell |
|
|||||
|
2016
Q2 | $14.6M | Sell |
|
|||||
|
2016
Q1 | $17.7M | Sell |
|
|||||
|
2015
Q4 | $24.6M | Sell |
|
|||||
|
2015
Q3 | $20.5M | Sell |
|
|||||
|
2015
Q2 | $23.8M | Buy |
|
|||||
|
2015
Q1 | $20.5M | Buy |
|
|||||
|
2014
Q4 | $21.8M | Sell |
|
|||||
|
2014
Q3 | $19.6M | Sell |
|
|||||
|
2014
Q2 | $18.8M | Sell |
|
|||||
|
2014
Q1 | $19.1M | Sell |
|
|||||
|
2013
Q4 | $16.8M | Sell |
|
|||||
|
2013
Q3 | $14.9M | Sell |
|
|||||
|
2013
Q2 | $11.9M | Buy |
|